Abstract # 2328 Modulation of EPCA-2 Levels in Men with Localized Prostate Cancer Treated with Radiation with or without Androgen Suppression Therapy

Presenter: Christodouleas, John

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

J. P. Christodouleas1, D. B. Yeater2, S. K. Jabbour1, L. Mangold2, E. S. Leman2, R. Drew1, E. Humphreys2, A. W. Partin2, R. H. Getzenberg2, T. L. DeWeese1, 1Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins Hospital, Baltimore, MD, 2Department of Urology, The Johns Hopkins Hospital, Baltimore, MD

Author Disclosure:
 J.P. Christodouleas, None; D.B. Yeater, Onconome Inc, B. Research Grant; S.K. Jabbour, None; L. Mangold, None; E.S. Leman, Onconome Inc, B. Research Grant; R. Drew, None; E. Humphreys, None; A.W. Partin, Patent royalties, G. Other; R.H. Getzenberg, Oncon

E-mail a friend about this abstract:
Enter email address: